SCHEMBL20107370

SCHEMBL20107370

NCCOCCOCC(=O)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
MAPK1 P28482 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 2/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A3 Q01959 1/20 0.45
KMT2A Q03164 1/20 0.45
IDO1 P14902 1/20 0.44
HCAR2 Q8TDS4 1/20 0.41
CDC25B P30305 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
SLC15A1 P46059 1/20 0.41
TP53 P04637 1/20 0.41
MAPT P10636 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30145598 0.98 ALDH1A1 (0.51) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL13250748 0.97 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
Hydrochloric Acid SCHEMBL29193056 0.95 ALDH1A1 (0.54) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL20107340 0.88 SMN1; SMN2 (0.56) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL24459137 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL22511822 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL16620755 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL21814470 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL14762052 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2
SCHEMBL17167174 0.88 ALDH1A1 (0.53) ALDH1A1MAPK1L3MBTL1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118085061-A Cyclic peptide tyrosine compounds as neuropeptide y receptor modulators 詹森药业有限公司 2024-05-28 CN disclosed
CN-110099692-B Cyclic peptide tyrosine compounds as neuropeptide y receptor modulators 詹森药业有限公司 2024-03-12 CN disclosed
US-20240018208-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2024-01-18 US disclosed
US-20230346949-A1 A METHOD OF FORMING A CONJUGATE OF A SULFONAMIDE AND A POLYPEPTIDE SANOFI SA (FR) 2023-11-02 US disclosed
US-11732019-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors JANSSEN PHARMACEUTICA NV (BE) 2023-08-22 US disclosed
US-20210206822-A1 Cyclic Peptide Tyrosine Tyrosine Compounds as Modulators of Neuropeptide Y Receptors JANSSEN PHARMACEUTICA NV (BE) 2021-07-08 US disclosed
US-10968264-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors JANSSEN PHARMACEUTICA NV (BE) 2021-04-06 US disclosed
US-10961293-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors JANSSEN PHARMACEUTICS NV (BE) 2021-03-30 US disclosed
US-20190345214-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2019-11-14 US disclosed
US-20180127476-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-10 US disclosed
WO-2018081367-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS JANSSEN PHARMACEUTICA NV (BE) 2018-05-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10961293-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-20210206822-A1 Cyclic Peptide Tyrosine Tyrosine Compounds as Modulators of Neuropeptide Y Receptors NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-20240018208-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-11732019-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-20180127476-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-20230346949-A1 A METHOD OF FORMING A CONJUGATE OF A SULFONAMIDE AND A POLYPEPTIDE IAPP, AMY2A, STS ALDH1A1 842/4885MAPK1 1479/4885L3MBTL1 4628/4885
US-10968264-B2 Cyclic peptide tyrosine tyrosine compounds as modulators of neuropeptide Y receptors NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885
US-20190345214-A1 CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS NPY4R, NPY5R, NPY1R ALDH1A1 4881/4885MAPK1 1224/4885L3MBTL1 1659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.